33.78
price up icon0.09%   0.03
 
loading
전일 마감가:
$33.75
열려 있는:
$33.71
하루 거래량:
2.74M
Relative Volume:
0.63
시가총액:
$13.85B
수익:
$2.26B
순이익/손실:
$1.09B
주가수익비율:
14.42
EPS:
2.3431
순현금흐름:
$2.70B
1주 성능:
+2.74%
1개월 성능:
+5.20%
6개월 성능:
+30.37%
1년 성능:
+24.70%
1일 변동 폭
Value
$33.61
$33.97
1주일 범위
Value
$32.65
$33.97
52주 변동 폭
Value
$24.05
$34.31

로열티 파마 Stock (RPRX) Company Profile

Name
명칭
Royalty Pharma Plc
Name
전화
(212) 883-0200
Name
주소
110 EAST 59TH STREET, NEW YORK, NY
Name
직원
99
Name
트위터
Name
다음 수익 날짜
2025-02-11
Name
최신 SEC 제출 서류
Name
RPRX's Discussions on Twitter

RPRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RPRX
Royalty Pharma Plc
33.78 13.85B 2.26B 1.09B 2.70B 2.3431
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

로열티 파마 Stock (RPRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-16 개시 Morgan Stanley Overweight
2024-06-03 다운그레이드 UBS Buy → Neutral
2022-06-14 재개 UBS Buy
2022-05-13 개시 Scotiabank Sector Outperform
2022-04-27 개시 Goldman Buy
2022-04-14 업그레이드 JP Morgan Neutral → Overweight
2022-04-06 재개 Morgan Stanley Overweight
2021-10-29 업그레이드 Citigroup Neutral → Buy
2021-07-30 개시 Tigress Financial Buy
2020-11-09 업그레이드 UBS Neutral → Buy
2020-07-14 개시 Evercore ISI In-line
2020-07-13 개시 BofA Securities Buy
2020-07-13 개시 Citigroup Neutral
2020-07-13 개시 Cowen Outperform
2020-07-13 개시 Goldman Neutral
2020-07-13 개시 JP Morgan Neutral
2020-07-13 개시 Morgan Stanley Equal-Weight
2020-07-13 개시 SunTrust Buy
2020-07-13 개시 UBS Neutral
모두보기

로열티 파마 주식(RPRX)의 최신 뉴스

pulisher
Jun 06, 2025

Ameriprise Financial Inc. Sells 23,786 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Jun 06, 2025
pulisher
Jun 04, 2025

Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

Royalty Pharma to Share Strategic Updates at Goldman Sachs Healthcare Conference 2025 - Stock Titan

Jun 04, 2025
pulisher
Jun 04, 2025

(RPRX) Technical Data - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 03, 2025

Mackenzie Financial Corp Increases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

California State Teachers Retirement System Grows Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

33,531 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by 111 Capital - MarketBeat

Jun 03, 2025
pulisher
Jun 02, 2025

Royalty Pharma plc (NASDAQ:RPRX) On An Uptrend: Could Fundamentals Be Driving The Stock? - Yahoo Finance

Jun 02, 2025
pulisher
Jun 02, 2025

150,344 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by Lansforsakringar Fondforvaltning AB publ - MarketBeat

Jun 02, 2025
pulisher
May 31, 2025

Royalty Pharma plc (NASDAQ:RPRX) Stock Position Trimmed by Tidal Investments LLC - MarketBeat

May 31, 2025
pulisher
May 30, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 350,315 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 30, 2025
pulisher
May 30, 2025

GF Fund Management CO. LTD. Invests $238,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 30, 2025
pulisher
May 29, 2025

Squarepoint Ops LLC Lowers Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 29, 2025
pulisher
May 28, 2025

Janus Henderson Group PLC Decreases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

University of Texas Texas AM Investment Management Co. Purchases New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Nuveen Asset Management LLC Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Quantinno Capital Management LP Grows Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 27, 2025
pulisher
May 26, 2025

State of Wyoming Has $385,000 Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 26, 2025
pulisher
May 26, 2025

Captrust Financial Advisors Lowers Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 26, 2025
pulisher
May 26, 2025

Two Sigma Investments LP Has $61.74 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 26, 2025
pulisher
May 26, 2025

Worldquant Millennium Advisors LLC Has $15.57 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 26, 2025
pulisher
May 25, 2025

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Point72 Asset Management L.P. - MarketBeat

May 25, 2025
pulisher
May 25, 2025

USS Investment Management Ltd Lowers Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 25, 2025
pulisher
May 24, 2025

How to Take Advantage of moves in (RPRX) - news.stocktradersdaily.com

May 24, 2025
pulisher
May 24, 2025

Raiffeisen Bank International AG Makes New $506,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 24, 2025
pulisher
May 24, 2025

Two Sigma Advisers LP Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 24, 2025
pulisher
May 22, 2025

Challenging Environment For Biopharma Is A Tailwind For Royalty Pharma - insights.citeline.com

May 22, 2025
pulisher
May 22, 2025

Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Man Group plc - MarketBeat

May 22, 2025
pulisher
May 22, 2025

Royalty Pharma (NASDAQ:RPRX) Stock Rating Lowered by StockNews.com - Defense World

May 22, 2025
pulisher
May 22, 2025

Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

May 22, 2025
pulisher
May 21, 2025

Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by Ethic Inc. - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Royalty Pharma plc (NASDAQ:RPRX) Stock Holdings Trimmed by OMERS ADMINISTRATION Corp - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Royalty Pharma at RBC Capital Markets: Strategic Funding Insights By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 20, 2025

Transcript : Royalty Pharma plc Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 04 - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Occudo Quantitative Strategies LP Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 20, 2025
pulisher
May 20, 2025

RPRX Stock Performance Following Recent Offering Details | RPRX - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Royalty Pharma plc (NASDAQ:RPRX) Holdings Trimmed by Captrust Financial Advisors - Defense World

May 20, 2025
pulisher
May 20, 2025

Royalty Pharma plc (NASDAQ:RPRX) Receives $42.50 Consensus PT from Analysts - Defense World

May 20, 2025
pulisher
May 19, 2025

Patient Capital Management LLC Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Royalty Pharma completes major acquisition By Investing.com - Investing.com Canada

May 19, 2025

로열티 파마 (RPRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.59
price up icon 4.36%
$22.20
price up icon 1.79%
$73.62
price up icon 1.21%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
자본화:     |  볼륨(24시간):